BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25014136)

  • 1. The RNA expression signature of the HepG2 cell line as determined by the integrated analysis of miRNA and mRNA expression profiles.
    Bai Y; Xue Y; Xie X; Yu T; Zhu Y; Ge Q; Lu Z
    Gene; 2014 Sep; 548(1):91-100. PubMed ID: 25014136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of microRNA and mRNA expression profiles highlights aldehyde-induced inflammatory responses in cells relevant for lung toxicity.
    Song MK; Lee HS; Ryu JC
    Toxicology; 2015 Aug; 334():111-21. PubMed ID: 26079696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Expression Profiling and Functional Network Analysis of p53-Regulated MicroRNAs in HepG2 Cells Treated with Doxorubicin.
    Yang Y; Liu W; Ding R; Xiong L; Dou R; Zhang Y; Guo Z
    PLoS One; 2016; 11(2):e0149227. PubMed ID: 26886852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of differentially expressed mRNAs and miRNAs between hepatocellular carcinoma and their matched adjacent normal liver tissues.
    Gao B; Ning S; Li J; Liu H; Wei W; Wu F; Tang Y; Feng Y; Li K; Zhang L
    Oncol Rep; 2015 Jul; 34(1):325-33. PubMed ID: 26062888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression signature of human HepG2 cell line.
    Costantini S; Di Bernardo G; Cammarota M; Castello G; Colonna G
    Gene; 2013 Apr; 518(2):335-45. PubMed ID: 23357223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
    He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
    Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of MicroRNAs and target genes involvement in hepatocellular carcinoma with microarray data.
    Wang D; Tan J; Xu Y; Tan X; Han M; Tu Y; Zhu Z; Zen J; Dou C; Cai S
    Hepatogastroenterology; 2015; 62(138):378-82. PubMed ID: 25916067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cells.
    Ding M; Li J; Yu Y; Liu H; Yan Z; Wang J; Qian Q
    J Transl Med; 2015 Aug; 13():259. PubMed ID: 26259570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of miRNA and mRNA transcriptomes during amelogenesis.
    Yin K; Hacia JG; Zhong Z; Paine ML
    BMC Genomics; 2014 Nov; 15(1):998. PubMed ID: 25406666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
    Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
    Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
    Najafi A; Tavallaei M; Hosseini SM
    Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritizing breast cancer subtype related miRNAs using miRNA-mRNA dysregulated relationships extracted from their dual expression profiling.
    Hua L; Zhou P; Li L; Liu H; Yang Z
    J Theor Biol; 2013 Aug; 331():1-11. PubMed ID: 23619378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression networks in COPD: microRNA and mRNA regulation.
    Ezzie ME; Crawford M; Cho JH; Orellana R; Zhang S; Gelinas R; Batte K; Yu L; Nuovo G; Galas D; Diaz P; Wang K; Nana-Sinkam SP
    Thorax; 2012 Feb; 67(2):122-31. PubMed ID: 21940491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
    Zhuo L; Liu J; Wang B; Gao M; Huang A
    Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of miRNA-mRNA crosstalk in pancreatic cancer by integrating transcriptome analysis.
    Yang J; Zeng Y
    Eur Rev Med Pharmacol Sci; 2015; 19(5):825-34. PubMed ID: 25807437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of microRNA-mRNA reveals roles of microRNAs in cervical cancer.
    Ma D; Zhang YY; Guo YL; Li ZJ; Geng L
    Chin Med J (Engl); 2012 Dec; 125(23):4270-6. PubMed ID: 23217399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
    Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
    BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
    Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
    J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
    Thurnherr T; Mah WC; Lei Z; Jin Y; Rozen SG; Lee CG
    Sci Rep; 2016 Jan; 6():20065. PubMed ID: 26817861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.